Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.

    Thomas R, Apps R, Qi Y, Gao X, Male V, O'huigin C, O'Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Martin MP, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M.

    Nat Genet. 2009 Nov 22. [Epub ahead of print]PMID: 19935663 [PubMed - as supplied by publisher]

    2.

    Impact of HIV Infection on Diastolic Function and Left Ventricular Mass.

    Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF.

    Circ Heart Fail. 2009 Nov 20. [Epub ahead of print]PMID: 19933410 [PubMed - as supplied by publisher]

    3.

    Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.

    Deeks SG.

    Top HIV Med. 2009 Sep-Oct;17(4):118-23.PMID: 19890183 [PubMed - in process]Related articlesFree article

    4.

    Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

    Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD.

    Clin Infect Dis. 2009 Nov 15;49(10):1582-90.PMID: 19845473 [PubMed - in process]Related articles

    5.

    The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.

    Rosenblum M, Deeks SG, van der Laan M, Bangsberg DR.

    PLoS One. 2009 Sep 29;4(9):e7196.PMID: 19787058 [PubMed - in process]Related articlesFree article

    6.

    Reduced thymus activity and infection prematurely age the immune system.

    Gress RE, Deeks SG.

    J Clin Invest. 2009 Oct;119(10):2884-7. doi: 10.1172/JCI40855. Epub 2009 Sep 21.PMID: 19770512 [PubMed - in process]Related articles

    7.

    Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach.

    Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, Glidden DV, Deeks SG, Martin JN.

    J Acquir Immune Defic Syndr. 2009 Sep 10. [Epub ahead of print]PMID: 19745753 [PubMed - as supplied by publisher]Related articles

    8.

    HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy.

    Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG.

    AIDS. 2009 Oct 23;23(16):2143-9.PMID: 19684507 [PubMed - in process]Related articles

    9.

    Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals.

    Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ.

    AIDS Res Hum Retroviruses. 2009 Aug;25(8):795-802.PMID: 19678765 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.

    Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, Wachter DJ, Martin JN, Deeks SG, Rosenberg MG, Nixon DF, Garrison KE.

    Mol Biol Evol. 2009 Nov;26(11):2617-26. Epub 2009 Aug 10.PMID: 19666991 [PubMed - in process]Related articlesFree article

    11.

    Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.

    Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, Rosenberg MG, Sandberg JK, Kallas EG, Nixon DF.

    AIDS. 2009 Sep 24;23(15):1965-70.PMID: 19590406 [PubMed - in process]Related articles

    12.

    Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses.

    Garrison KE, Champiat S, York VA, Agrawal AT, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF.

    Clin Vaccine Immunol. 2009 Sep;16(9):1369-71. Epub 2009 Jul 1.PMID: 19571107 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients.

    Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, Hatano H, Xie Y, Martin JN, Ganz P, Deeks SG.

    AIDS. 2009 Sep 24;23(15):2021-7.PMID: 19542863 [PubMed - in process]Related articles

    14.

    A step ahead on the HIV collaboratory.

    Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ, Papagno L, Schacker TW, Wain-Hobson S, Walker BD, Youle M.

    Science. 2009 Jun 5;324(5932):1264-5. No abstract available. PMID: 19498149 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.

    Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, Martin JN, Deeks SG.

    AIDS. 2009 Jun 1;23(9):1059-67.PMID: 19390417 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.

    Jacobson MA, Ditmer DP, Sinclair E, Martin JN, Deeks SG, Hunt P, Mocarski ES, Shiboski C.

    PLoS One. 2009;4(4):e5277. Epub 2009 Apr 17.PMID: 19381272 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators.

    N Engl J Med. 2009 Apr 30;360(18):1815-26. Epub 2009 Apr 1.PMID: 19339714 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

    Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, Rodriguez B, Landay A, Martin J, Sinclair E, Asher AI, Deeks SG, Douek DC, Brenchley JM.

    J Infect Dis. 2009 Apr 15;199(8):1177-85. Erratum in: J Infect Dis. 2009 Jul 1;200(1):160. PMID: 19265479 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.

    Tenorio AR, Jiang H, Zheng Y, Bastow B, Kuritzkes DR, Bartlett JA, Deeks SG, Landay AL, Riddler SA.

    AIDS Res Hum Retroviruses. 2009 Feb;25(2):135-9.PMID: 19239354 [PubMed - indexed for MEDLINE]Related articles

    20.

    Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

    Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, Martin JN, Deeks SG.

    Clin Infect Dis. 2009 Mar 15;48(6):787-94.PMID: 19193107 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...